DJ Terns Pharmaceuticals Shares Stumble in Trading Debut After IPO >TERN
By Colin Kellaher
Shares of Terns Pharmaceuticals Inc. fell in their trading debut Friday after the biopharmaceutical company's upsized initial public offering was priced at the top of expectations.
Terns shares were recently trading at $15.60, down 8.3%, after opening at $16.95.
The Foster City, Calif., company sold 7.5 million shares priced at $17 apiece, compared with prior plans to offer 6.25 million shares at between $15 and $17 each.
Write to Colin Kellaher at email@example.com
(END) Dow Jones Newswires
February 05, 2021 13:04 ET (18:04 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.